Engimmune Therapeutics
Developer of T-cell receptor-based therapeutics for cancer and autoimmune diseases
Funding snapshot
About
Developer of T-cell receptor-based therapeutics for cancer and autoimmune diseases. The company has proprietary technologies combining genome editing, functional high-throughput screening, deep sequencing, and machine learning to address T-cell receptor therapies for the treatment of cancer. Also, it is expanding its pipeline to treat autoimmune diseases.
Latest news
No articles yet.
Similar startups
PayFlow
Embedded payments infrastructure for Southeast Asian marketplaces and platforms.
GreenGrid
Software for planning and operating distributed battery storage across Europe.
Immuneel
Developer of T-cell therapies for the treatment of cancer
ImmunoACT
Developer of cell and gene therapies for cancer treatment
Raising like Engimmune Therapeutics?
Analyze your pitch deck before your next raise.
Analyze My Deck →